Hormone Therapy in Breast Cancer Survivors and Those at High Risk for Breast Cancer

Area of Science:

• Oncology
• Gynecology
• Menopause Management

Background:

• Fear of hormone therapy (HT) use is common in women and providers due to breast cancer risk concerns.
• Menopausal symptoms can be distressing and significantly impact quality of life.
• Navigating HT decisions in high-risk populations requires careful evidence evaluation.

Purpose of the Study:

• To examine the evidence for and against hormone therapy use in women with increased breast cancer risk.
• To address clinical situations involving family history, genetic mutations, and treatment-induced menopause.
• To provide guidance on managing menopausal symptoms while considering oncologic safety.

Main Methods:

• Literature review of studies on hormone therapy and breast cancer risk.
• Analysis of clinical evidence in specific high-risk patient groups.
• Evaluation of risk-benefit profiles for hormone therapy in indicated scenarios.

Main Results:

• Evidence supports judicious HT use in select high-risk women, including those with a positive family history.
• Women who have undergone risk-reducing surgery for genetic mutations may be candidates for HT.
• HT can be considered for premature menopause induced by breast cancer treatment, with careful monitoring.

Conclusions:

• Hormone therapy can be safely used for menopausal symptoms in specific high-risk women.
• Individualized risk assessment and shared decision-making are crucial.
• Further research is needed to refine guidelines for HT use in oncologic populations.